GONADAL TOXICITIES IN EMBRYONAL BRAIN TUMOR SURVIVORS TREATED ON THE SJMB96 TRIAL INCLUDING RISK ADAPTED CRANIOSPINAL AND CONFORMAL PRIMARY-SITE IRRADIATION AND HIGH DOSE CHEMOTHERAPY WITH STEM CELL RESCUE

被引：0
|
作者：
DeWire, M. D. [1 ]
Merchant, T. E. [1 ]
Sklar, C. A. [2 ]
Armstrong, G. T. [1 ]
Broniscer, A. [1 ]
Morris, E. B. [1 ]
Qaddoumi, I. [1 ]
Shelso, J. [1 ]
Lesh, S. [1 ]
Wallace, D. [1 ]
Gajjar, A. [1 ]
机构：
[1] St Jude Childrens Hosp, Memphis, TN 38105 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：II114 / II114
页数：1
相关论文
共 13 条
  • [1] Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial
    Laughton, Stephen J.
    Merchant, Thomas E.
    Sklar, Charles A.
    Kun, Larry E.
    Fouladi, Maryam
    Broniscer, Alberto
    Morris, E. Brannon
    Sanders, Robert P.
    Krasin, Matthew J.
    Shelso, John
    Xiong, Zang
    Wallace, Dana
    Gajjar, Amar
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1112 - 1118
  • [2] Endocrine outcomes for children with medulloblastoma treated with craniospinal and conformal primary site irradiation on the SJMB96 trial
    Laughton, S. J.
    Merchant, T. E.
    Broniscer, A.
    Fouladi, M.
    Kun, L. E.
    Gajjar, A.
    NEURO-ONCOLOGY, 2007, 9 (02) : 170 - 170
  • [3] Endocrine Outcomes With Craniospinal and Local Irradiation and SJMB-96 Based High-dose Chemotherapy With Stem Cell Rescue for Average Risk Medulloblastoma
    Hiroshima, Shota
    Kubo, Nobuhiro
    Shin, Changsu
    Kasahara, Yasusi
    Iwabuchi, Haruko
    Nagasaki, Keisuke
    Imamura, Masaru
    Imai, Chihaya
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S86 - S87
  • [4] RISK-ADAPTED CRANIOSPINAL RADIOTHERAPY FOLLOWED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL RESCUE IN CHILDREN WITH LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA: RESULTS FROM ST. JUDE MEDULLOBLASTOMA 96 (SJMB96) AND ST. JUDE MEDULLOBLASTOMA 03 (SJMB03)
    Wright, K. D.
    Chintagumpala, M.
    Hassall, T.
    Ashley, D. M.
    Bouffet, E.
    Kellie, S. J.
    Gururangan, S.
    Cohn, R.
    Fisher, M.
    Broniscer, A.
    Qaddoumi, I.
    Morris, E. B.
    Armstrong, G.
    Merchant, T. E.
    Panandiker, A. Pai
    Ellison, D. W.
    Lesh, S.
    Wallace, D.
    Gajjar, A.
    NEURO-ONCOLOGY, 2010, 12 (06) : II5 - II6
  • [5] High-Dose Chemotherapy With Stem Cell Transplant to Delay Craniospinal Irradiation in Pediatric Embryonal Brain Tumor Patients
    Raleigh, D.
    Tomlin, B.
    Del Buono, B.
    Roddy, E.
    Sear, K.
    Byer, L.
    Felton, E.
    Banerjee, A.
    Torkildson, J.
    Samuel, D.
    Horn, B.
    Braunstein, S. E.
    Haas-Kogan, D. A.
    Mueller, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S231 - S231
  • [6] Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
    Utriainen, Pauliina
    Suominen, Anu
    Makitie, Outi
    Jahnukainen, Kirsi
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [7] Excellent event-free survival (EFS) in newly diagnosed high-risk (HR) medulloblastoma (MB) treated with craniospinal radiation (CSI) therapy followed by 4 cycles of high-dose chemotherapy and stem cell rescue: Results of a prospective multicenter trial (SJMB 96)
    Gaijar, A
    Chintagumpala, M
    Kellie, S
    Ashley, D
    Hassall, T
    Wallace, D
    Hale, G
    Broniscer, A
    Fouladi, M
    Merchant, T
    Krasin, M
    Woo, S
    Sexton, M
    Ahem, V
    Cheuk, R
    Lau, C
    Gilbertson, R
    Kun, L
    NEURO-ONCOLOGY, 2004, 6 (04) : 455 - 455
  • [8] Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
    Gajjar, Amar
    Chintagumpala, Murali
    Ashley, David
    Kellie, Stewart
    Kun, Larry E.
    Merchant, Thomas E.
    Woo, Shaio
    Wheeler, Greg
    Ahern, Valerie
    Krasin, Matthew J.
    Fouladi, Maryam
    Broniscer, Alberto
    Krance, Robert
    Hale, Gregory A.
    Stewart, Clinton F.
    Dauser, Robert
    Sanford, Robert A.
    Fuller, Christine
    Lau, Ching
    Boyett, James M.
    Wallace, Dana
    Gilbertson, Richard J.
    LANCET ONCOLOGY, 2006, 7 (10): : 813 - 820
  • [9] TANDEM HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOLLOWED BY RISK-ADAPTED RADIATION IN CHILDREN WITH HIGH-RISK CEREBRAL PRIMITIVE NEUROECTODERMAL TUMOR: RESULTS OF THE SFCE-TRIAL PNET HR+5
    Dufour, C.
    Delisle, M. B.
    Geoffray, A.
    Laplanche, A.
    Frappaz, D.
    Icher, C.
    Bertozzi, A. I.
    Leblond, P.
    Doz, F.
    Andre, N.
    DeCarli, E.
    Schneider, P.
    Berger, C.
    Lejars, O.
    Chastagner, P.
    Pagnier, A.
    Soler, C.
    Werle, N. Entz
    Couanet, D. Valteau
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S111 - S111
  • [10] Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblostoma-96): Long-term results from a prospective, multicentre trial (vol 7, pg 813, 2006)
    Gajjar, A.
    Chintagumpala, M.
    Ashley, D.
    LANCET ONCOLOGY, 2006, 7 (10): : 797 - 797
12